[{"Assets_0_Q2_USD":316704010.0,"CommonStockSharesOutstanding_0_Q2_shares":63672430.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-75466122.0,"NetIncomeLoss_1_Q2_USD":-71090164.0,"NetIncomeLoss_2_Q2_USD":-121664531.0,"StockholdersEquity_0_Q2_USD":159086038.0,"Ticker":"APLS","CIK":"1492422","name":"APELLIS PHARMACEUTICALS, INC.","OfficialName":"Apellis Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5553923312.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190731"}]